The CMR Examination in Heart Failure

American Heart Association, 2008 Redfield, 2003, Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic, JAMA, 289, 194, 10.1001/jama.289.2.194 Hunt, 2005, Circulation, 112, e154 Leier, 2007, The physical examination in heart failure. Part II, Congest Heart Fail, 13, 99, 10.1111/j.1527-5299.2007.06491.x Leier, 2007, The physical examination in heart failure. Part I, Congest Heart Fail, 13, 41, 10.1111/j.1527-5299.2007.06409.x McCrohon, 2003, Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance, Circulation, 108, 54, 10.1161/01.CIR.0000078641.19365.4C Kass, 2003, Predicting cardiac resynchronization response by QRS duration: the long and short of it, J Am Coll Cardiol, 42, 2125, 10.1016/j.jacc.2003.09.021 Collins, 2006, Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure, Ann Emerg Med, 47, 13, 10.1016/j.annemergmed.2005.04.003 Maisel, 2002, Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure, N Engl J Med, 347, 161, 10.1056/NEJMoa020233 Nemes, 2007, Usefulness of ultrasound contrast agent to improve image quality during real-time three-dimensional stress echocardiography, Am J Cardiol, 99, 275, 10.1016/j.amjcard.2006.08.023 Di Carli, 1998, Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions, J Thorac Cardiovasc Surg, 116, 997, 10.1016/S0022-5223(98)70052-2 Schinkel, 2007, Assessment of myocardial viability in patients with heart failure, J Nucl Med, 48, 1135, 10.2967/jnumed.106.038851 Gutberlet, 2005, Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization, Eur Radiol, 15, 872, 10.1007/s00330-005-2653-9 Cooper, 2007, The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology, Circulation, 116, 2216, 10.1161/CIRCULATIONAHA.107.186093 Shields, 2002, The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis, J Card Fail, 8, 74, 10.1054/jcaf.2002.32196 Binanay, 2005, Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial, JAMA, 294, 1625, 10.1001/jama.294.13.1625 Boyle, 2007, Myocellular and interstitial edema and circulating volume expansion as a cause of morbidity and mortality in heart failure, J Card Fail, 13, 133, 10.1016/j.cardfail.2006.10.015 Varnava, 2001, Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy, Am J Cardiol, 88, 275, 10.1016/S0002-9149(01)01640-X Delcayre, 2002, Molecular mechanisms of myocardial remodeling: the role of aldosterone, J Mol Cell Cardiol, 34, 1577, 10.1006/jmcc.2002.2088 Struthers, 2004, Aldosterone-induced vasculopathy, Mol Cell Endocrinol, 217, 239, 10.1016/j.mce.2003.10.024 Frohlich, 2001, Fibrosis and ischemia: the real risks in hypertensive heart disease, Am J Hypertens, 14, 194S, 10.1016/S0895-7061(01)02088-X Grothues, 2004, Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance, Am Heart J, 147, 218, 10.1016/j.ahj.2003.10.005 Grothues, 2002, Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy, Am J Cardiol, 90, 29, 10.1016/S0002-9149(02)02381-0 Pennell, 2002, Ventricular volume and mass by CMR, J Cardiovasc Magn Reson, 4, 507, 10.1081/JCMR-120016389 Carr, 2001, Cine MR angiography of the heart with segmented true fast imaging with steady-state precession, Radiology, 219, 828, 10.1148/radiology.219.3.r01jn44828 Kellman, 2001, Adaptive sensitivity encoding incorporating temporal filtering (TSENSE), Magn Reson Med, 45, 846, 10.1002/mrm.1113 Pruessmann, 2001, Sensitivity encoded cardiac MRI, J Cardiovasc Magn Reson, 3, 1, 10.1081/JCMR-100000143 Lee, 2002, Cardiac function: MR evaluation in one breath hold with real-time true fast imaging with steady-state precession, Radiology, 222, 835, 10.1148/radiol.2223011156 Firmin, 1990, The application of phase shifts in NMR for flow measurement, Magn Reson Med, 14, 230, 10.1002/mrm.1910140209 O'Donnell, 1985, NMR blood flow imaging using multiecho, phase contrast sequences, Med Phys, 12, 59, 10.1118/1.595736 Kondo, 1991, Right and left ventricular stroke volume measurements with velocity-encoded cine MR imaging: in vitro and in vivo validation, AJR Am J Roentgenol, 157, 9, 10.2214/ajr.157.1.2048544 Firmin, 1987, In vivo validation of MR velocity imaging, J Comput Assist Tomogr, 11, 751, 10.1097/00004728-198709000-00001 Hoeper, 2001, Evaluation of right ventricular performance with a right ventricular ejection fraction thermodilution catheter and MRI in patients with pulmonary hypertension, Chest, 120, 502, 10.1378/chest.120.2.502 Lee, 1997, Flow quantification using fast cine phase-contrast MR imaging, conventional cine phase-contrast MR imaging, and Doppler sonography: in vitro and in vivo validation, AJR Am J Roentgenol, 169, 1125, 10.2214/ajr.169.4.9308476 Jung, 2006, Detailed analysis of myocardial motion in volunteers and patients using high-temporal-resolution MR tissue phase mapping, J Magn Reson Imaging, 24, 1033, 10.1002/jmri.20703 Beerbaum, 2005, Blood flow quantification in adults by phase-contrast MRI combined with SENSE: a validation study, J Cardiovasc Magn Reson, 7, 361, 10.1081/JCMR-200053538 Aletras, 1999, High-resolution strain analysis of the human heart with fast-DENSE, J Magn Reson, 140, 41, 10.1006/jmre.1999.1821 Aletras, 1999, DENSE: displacement encoding with stimulated echoes in cardiac functional MRI, J Magn Reson, 137, 247, 10.1006/jmre.1998.1676 Kim, 2004, Myocardial tissue tracking with two-dimensional cine displacement-encoded MR imaging: development and initial evaluation, Radiology, 230, 862, 10.1148/radiol.2303021213 Wen, 2008, Adaptive postprocessing techniques for myocardial tissue tracking with displacement-encoded MRI, Radiology, 246, 229, 10.1148/radiol.2461070053 Manning, 1991, First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease, J Am Coll Cardiol, 18, 959, 10.1016/0735-1097(91)90754-W Jekic, 2008, Cardiac function and myocardial perfusion immediately following maximal treadmill exercise inside the MRI room, J Cardiovasc Magn Reson, 10, 3, 10.1186/1532-429X-10-3 Bohl, 2008, Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease, Int J Cardiovasc Imaging, 24, 597, 10.1007/s10554-008-9300-x Mahrholdt, 2005, Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies, Eur Heart J, 26, 1461, 10.1093/eurheartj/ehi258 Rehwald, 2002, Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury, Circulation, 105, 224, 10.1161/hc0202.102016 Flacke, 2001, Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction, Radiology, 218, 703, 10.1148/radiology.218.3.r01fe18703 Daniel, 2007, Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction, Magn Reson Med, 58, 34, 10.1002/mrm.21272 Simonetti, 2001, An improved MR imaging technique for the visualization of myocardial infarction, Radiology, 218, 215, 10.1148/radiology.218.1.r01ja50215 Chung, 2002, Infarct imaging in a single heart-beat, J Cardiovasc Magn Reson, 4, 12 Kellman, 2002, Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement, Magn Reson Med, 47, 372, 10.1002/mrm.10051 Bauner, 2007, Inversion recovery single-shot TurboFLASH for assessment of myocardial infarction at 3 Tesla, Invest Radiol, 42, 361, 10.1097/01.rli.0000262565.89298.59 Sparrow, 2006, Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study, AJR Am J Roentgenol, 187, W630, 10.2214/AJR.05.1264 Simonetti, 1996, Black blood: T2-weighted inversion-recovery MR imaging of the heart, Radiology, 199, 49, 10.1148/radiology.199.1.8633172 Abdel-Aty, 2007, T2-weighted cardiovascular magnetic resonance imaging, J Magn Reson Imaging, 26, 452, 10.1002/jmri.21028 Zagrosek, 2008, Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis: a CMR study, J Cardiovasc Magn Reson, 10, 19, 10.1186/1532-429X-10-19 Schulz-Menger, 2006, Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance, Heart, 92, 399, 10.1136/hrt.2004.058016 Abdel-Aty, 2004, Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction, Circulation, 109, 2411, 10.1161/01.CIR.0000127428.10985.C6 Aletras, 2008, ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart, Magn Reson Med, 59, 229, 10.1002/mrm.21490 Kellman, 2007, T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo, Magn Reson Med, 57, 891, 10.1002/mrm.21215 Anderson, 2001, Cardiovascular T2-star (T2∗) magnetic resonance for the early diagnosis of myocardial iron overload, Eur Heart J, 22, 2171, 10.1053/euhj.2001.2822 Wood, 2005, MRI R2 and R2∗ mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients, Blood, 106, 1460, 10.1182/blood-2004-10-3982 Neubauer, 2007, The failing heart: an engine out of fuel, N Engl J Med, 356, 1140, 10.1056/NEJMra063052 Ten Hove, 2007, MR spectroscopy in heart failure: clinical and experimental findings, Heart Fail Rev, 12, 48, 10.1007/s10741-007-9003-8 Ten Hove, 2008, The application of NMR spectroscopy for the study of heart failure, Curr Pharm Des, 14, 1787, 10.2174/138161208784746743 Reingold, 2005, Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method, Am J Physiol Endocrinol Metab, 289, E935, 10.1152/ajpendo.00095.2005 Szczepaniak, 2003, Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging, Magn Reson Med, 49, 417, 10.1002/mrm.10372 Szczepaniak, 2007, Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America, Circ Res, 101, 759, 10.1161/CIRCRESAHA.107.160457 Wu, 1998, Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction, Circulation, 97, 765, 10.1161/01.CIR.97.8.765 Albert, 2006, Assessment of no-reflow regions using cardiac MRI, Basic Res Cardiol, 101, 383, 10.1007/s00395-006-0617-0 Panting, 2002, Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging, N Engl J Med, 346, 1948, 10.1056/NEJMoa012369 Marantz, 1992, Prognosis in ischemic heart disease: can you tell as much at the bedside as in the nuclear laboratory?, Arch Intern Med, 152, 2433, 10.1001/archinte.1992.00400240055009 Lloyd, 2006, Use of cardiac magnetic resonance imaging in surgical ventricular restoration, Eur J Cardiothorac Surg, 29, S216, 10.1016/j.ejcts.2006.02.006 Moon, 2004, The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy, J Am Coll Cardiol, 43, 2260, 10.1016/j.jacc.2004.03.035 Raman, 2007, Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction, J Cardiovasc Magn Reson, 9, 907, 10.1080/10976640701693733 Keren, 2008, Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression, Nat Clin Pract Cardiovasc Med, 5, 158, 10.1038/ncpcardio1110 Maron, 2008, Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status, Am J Cardiol, 101, 544, 10.1016/j.amjcard.2007.09.101 Moon, 2005, Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I, Heart, 91, 1036, 10.1136/hrt.2004.041384 Dhoble, 2008, Likelihood of ventricular arrhythmias due to myocardial fibrosis in hypertrophic cardiomyopathy as detected by cardiac magnetic resonance imaging, J Am Coll Cardiol, 52, 969, 10.1016/j.jacc.2008.05.050 Adabag, 2008, Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance, J Am Coll Cardiol, 51, 1369, 10.1016/j.jacc.2007.11.071 Mahrholdt, 2004, Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology, Circulation, 109, 1250, 10.1161/01.CIR.0000118493.13323.81 Serra, 2003, Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging, Circulation, 107, e188, 10.1161/01.CIR.0000062400.74155.E6 Shimada, 2001, Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging, Am J Med, 110, 520, 10.1016/S0002-9343(01)00677-5 Maceira, 2005, Cardiovascular magnetic resonance in cardiac amyloidosis, Circulation, 111, 186, 10.1161/01.CIR.0000152819.97857.9D Moon, 2006, The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease, J Cardiovasc Magn Reson, 8, 479, 10.1080/10976640600605002 Rochitte, 2005, Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity, J Am Coll Cardiol, 46, 1553, 10.1016/j.jacc.2005.06.067 Silva, 2007, Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy, J Am Coll Cardiol, 49, 1874, 10.1016/j.jacc.2006.10.078 Tandri, 2005, Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging, J Am Coll Cardiol, 45, 98, 10.1016/j.jacc.2004.09.053 Corrado, 1997, Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study, J Am Coll Cardiol, 30, 1512, 10.1016/S0735-1097(97)00332-X Kim, 2008, Images in cardiovascular medicine: chronic cardiac transplant rejection. Evaluation with magnetic resonance imaging, Circulation, 118, 885, 10.1161/CIRCULATIONAHA.108.770040 Rathi, 2008, Routine evaluation of left ventricular diastolic function by cardiovascular magnetic resonance: a practical approach, J Cardiovasc Magn Reson, 10, 36, 10.1186/1532-429X-10-36 Gotte, 2006, Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function, J Am Coll Cardiol, 48, 2002, 10.1016/j.jacc.2006.07.048 Sorensen, 2004, Operator-independent isotropic three-dimensional magnetic resonance imaging for morphology in congenital heart disease: a validation study, Circulation, 110, 163, 10.1161/01.CIR.0000134282.35183.AD Stauder, 2007, Assessment of coronary artery bypass grafts by magnetic resonance imaging, Br J Radiol, 80, 975, 10.1259/bjr/26167398 Bleeker, 2006, Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy, Circulation, 113, 969, 10.1161/CIRCULATIONAHA.105.543678 Kim, 2000, The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction, N Engl J Med, 343, 1445, 10.1056/NEJM200011163432003 Bello, 2003, Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy, Circulation, 108, 1945, 10.1161/01.CIR.0000095029.57483.60